Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potassium channels and erectile dysfunction.

Stephen L Archer1

  • 12C2.36 Walter Mackenzie Health Sciences Centre, Department of Medicine (Cardiology), Vascular Biology Group, University of Alberta, Edmonton, AB, Canada T6G 2B7. sarcher@cha.ab.ca

Vascular Pharmacology
|October 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance.

Nature cell biology·2026
Same author

Dynamin 2 Regulates Mitochondrial Mitotic Fission in Pulmonary Hypertension.

Circulation research·2026
Same author

Incident Atrial Fibrillation and Flutter in Patients With Pulmonary Arterial Hypertension: Influence of Right Ventricular Dilatation and Reduced Right Atrial Function.

Journal of the American Heart Association·2026
Same author

SARS-CoV-2 targets mitochondria, exacerbating COVID-19 pneumonia.

The Journal of physiology·2026
Same author

Macrophage plasticity and glucose metabolism: the role of immunometabolism in pulmonary arterial hypertension.

Clinical science (London, England : 1979)·2025
Same author

Germline and somatic variants in DNMT3A and other clonal haematopoiesis of indeterminate potential genes contribute to pulmonary arterial hypertension.

European heart journal·2025
Same journal

Interplay between Na<sup>+</sup>/K<sup>+</sup>-ATPase-dependent Src-mediated Ca<sup>2+</sup> sensitization and BK<sub>Ca</sub> channel negative feedback regulates rat mesenteric artery contraction.

Vascular pharmacology·2026
Same journal

Generation and validation of a Myh11Dre-Spp1Cre intersectional mouse model for lineage tracing of disease-associated smooth muscle cell states.

Vascular pharmacology·2026
Same journal

Prediction of peri-procedural cerebrovascular accidents in patients with severe peripheral artery disease undergoing transcatheter aortic valve replacement.

Vascular pharmacology·2026
Same journal

Vascularized tumor organoids as models for interpreting therapeutic response.

Vascular pharmacology·2026
Same journal

Spermidine ameliorates BK channel dysfunction in diabetic coronary smooth muscle cells via PKM2/STAT3/FBXO32 axis.

Vascular pharmacology·2026
Same journal

Reassessing the role of PPARgamma in vascular effects of cannabinoids: A critical appraisal.

Vascular pharmacology·2026
See all related articles

Erectile dysfunction (ED) is linked to aging and vascular issues. Enhancing nitric oxide (NO) pathways and calcium-sensitive potassium channels (BKCa) shows promise for treating ED.

Area of Science:

  • Urology
  • Vascular Biology
  • Molecular Medicine

Background:

  • Erectile dysfunction (ED) prevalence rises with age and vascular disease risk factors like diabetes and hypertension.
  • Penile erection involves nitric oxide (NO) synthesis, leading to smooth muscle cell relaxation and blood engorgement.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying erectile function and dysfunction.
  • To identify potential therapeutic targets for erectile dysfunction.

Main Methods:

  • The study reviews the signaling cascade from NO to cGMP-dependent protein kinase (PKG) activation.
  • It highlights the role of PKG in regulating ion channels, particularly BKCa channels, in smooth muscle cells.

Main Results:

Related Experiment Videos

  • PKG activation leads to smooth muscle relaxation by reducing intracellular calcium, partly via BKCa channels.
  • This mechanism is impaired in aging and vascular disease, contributing to ED.

Conclusions:

  • Augmenting nitric oxide synthase (NOS) expression, cGMP levels, or BKCa channel expression can treat experimental ED.
  • Future therapies may include gene transfer for K+ channels or using Type 5 phosphodiesterase (PDE5) inhibitors.